clock menu more-arrow no yes

Filed under:

PANEL URGES FDA TO OK ASTHMA DRUG

An advisory panel wants the Food and Drug Administration to approve Abbott Laboratories' Leutrol for treatment of asthma. It could become the first of a new class of drugs, known as leukotriene inhibiters, to treat the respiratory ailment.

The committee voted 7-1 Monday to recommend approval. The FDA is not obligated to follow recommendations from its panels of outside experts but usually does.Leutrol works by inhibiting substances, called leukotrienes, that cause lung passages in asthma sufferers to constrict, limiting the flow of air.

Tests of Leutrol in sufferers with mild to moderate cases of asthma showed improvement in lung functions and their asthma symptoms, said Dr. Robert Temple of the FDA.